[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340918-105":59,"doc-detail-340918-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identify-novel-inflammation-related-prognostic-signature-in-pancreatic-cancer-patients-research-study","Identify novel inflammation-related prognostic signature in pancreatic cancer patients - research study","","Pancreatic cancer has poor prognosis, and pancreatitis comorbidity further worsens outcomes, yet the prognostic role of inflammation remains unclear. The study screened TCGA gene expression and clinical data, performed GSEA and Cox regression to derive inflammation-related prognostic genes, and built a 3-gene risk score model (TRAF1, TYK2, MET). Kaplan–Meier and ROC analyses supported predictive performance. External validation from HPA and drug targeting via TISIDB and AUTODOCK suggested brigatinib targets MET, indicating therapeutic potential and biomarker value.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identify-novel-inflammation-related-prognostic-signature-in-pancreatic-cancer-patients-research-study/340918/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identify-novel-inflammation-related-prognostic-signature-in-pancreatic-cancer-patients-research-study/340918.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What inflammation-related prognostic model was constructed for pancreatic cancer patients?","Question",{"text":112,"@type":113},"A risk score system based on three inflammation-related genes: TRAF1, TYK2, and MET was constructed to stratify patients into high- and low-risk groups.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the model’s predictive ability evaluated?",{"text":117,"@type":113},"Kaplan–Meier survival curves and ROC curves were used to assess prognosis prediction, reporting statistical significance and AUC performance.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic target and supporting evidence were proposed?",{"text":121,"@type":113},"Using TISIDB and AUTODOCK, brigatinib was predicted to target MET, with molecular docking indicating favorable binding to MET.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340918,1790241120,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","®  \n Observational Study   \nIdentify novel inflammation-related prognostic signature in pancreatic cancer patients  \nYuan Sun, BMa , Xiaoying Zhang, BMb , Haiyan Zhu, BMa ,*  \n\n| Abstract\u003Cbr>Pancreatic cancer (PC) is a malignant tumor of the digestive system with a poor prognosis. PC patients with pancreatitis have a worse prognosis. But nobody reported the relationship between inflammation and prognosis in PC. Based on this, we are going to explore inflammation-related prognostic signature to predict patients’ survival and potential therapeutic target. We screened gene expression profile and corresponding clinical information of patients from The Cancer Genome Atlas (TCGA) database. Gene set enrichment analysis (GSEA) was performed to identify differentially expressed genes (DEGs) between tumor and normal tissues with P value \u003C .05. Univariate and multivariate Cox regression analysis was applied to identify possible prognostic inflammation genes and establish an inflammation-related risk score system, which was validated by Kaplan–Meier and Receiver operating characteristic (ROC) curves. Finally, we used the TISIDB database to predict targeted drugs for up-regulated gene hepatocyte growth factor receptor (MET) and used AUTODOCK software for molecular docking. We built a prognostic model consisted of 3 inflammation-related genes (tumor necrosis factor receptor associated factor 1/TFAR1, tyrosine kinase 2/TYK2, MET) . According to the median value of those genes’ risk score, PC patients were ranked into high- (88) and low-risk (89) groups. Then, the results of the Kaplan–Meier curves and the area under the curve (AUC) of the ROC curves showed this model had a good predictive power (P \u003C .001, AUC = 0.806) . The result of human protein atlas (HPA) database showed the expression of TRAF1 and TYK2 were low in pancreatic cancer, the expression of MET was high. TISIDB database founded brigatinib could target to MET. And AUTODOCK showed brigatinib had a nice docking with MET. Taken together, our study suggested that inflammation-associated prognostic signature might be used as novel biomarkers for predicting prognosis in PC patients and potential therapeutic target of the disease. |\n| --- |\n| Abbreviations: APLNR = apelin receptor, AREG = amphiregulin, AUC = area under the curve, CHST2 = GlcNAc6ST-1 , DEGs = differentially expressed genes, EREG = epiregulin, GO = gene ontology, GSEA = gene set enrichment analysis, KEGG = Kyoto Encyclopedia of Genes and Genomes, K–M = Kaplan–Meier, LAMB3 = laminin subunit beta 3, MET = hepatocyte growth factor receptor, NFKB1 = nuclear factor kappa B subunit 1, PC = pancreatic cancer, PCA = principal component analysis, PTPN6 = protein tyrosine phosphatase nonreceptor type 6, ROC = receiver operating characteristic, SCARF1 = scavenger receptor class F member 1, STAT4 = signal transducer and activator of transcription 4, TCGA = The Cancer Genome Atlas, TRAF1 = tumor necrosis factor receptor associated factor 1, t-SNE = t-distributed stochastic neighbor embedding, TYK2 = tyrosine kinase 2. |\n| Keywords: AUTODOCK, GSEA, inflammation, pancreatic cancer, prognostic signature |\n\n1. Introduction  \nPancreatic cancer (PC) is a highly malignant digestive system cancer with a poor prognosis and a 5-year survival rate of less than 5% following diagnosis.[1] PC was the fourth leading cause of cancer-related deaths in the United States, it was reported that 56,000 new cases and 47,050 deaths for PC patients in 2020.[2] Despite continuous advancements in technical and pharmacological management, the mortality rate of PC remains high. If the condition is not changed, the disease is expected  \nto be the second leading cause of cancer-related mortality in the next decade. [3,4] Therefore, identifying new prognosis biomarkers and therapeutic targets become key points to treat the disease.  \nInflammation was essential to the development and progression of the tumor. PC progression resulted from the creation and accumulati","cbCaicank3ifmPLa","https://ap.wps.com/l/cbCaicank3ifmPLa","pdf",1712839,11,"English","# Introduction\n# Highlights\n# Abstract","[{\"question\":\"What inflammation-related prognostic model was constructed for pancreatic cancer patients?\",\"answer\":\"A risk score system based on three inflammation-related genes: TRAF1, TYK2, and MET was constructed to stratify patients into high- and low-risk groups.\"},{\"question\":\"How was the model’s predictive ability evaluated?\",\"answer\":\"Kaplan–Meier survival curves and ROC curves were used to assess prognosis prediction, reporting statistical significance and AUC performance.\"},{\"question\":\"What therapeutic target and supporting evidence were proposed?\",\"answer\":\"Using TISIDB and AUTODOCK, brigatinib was predicted to target MET, with molecular docking indicating favorable binding to MET.\"}]","Identify novel inflammation-related prognostic signature in pancreatic cancer patients - research study | PDF",1790039554,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4457f1c86bd7d5710706cbeb614f4a9.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d641d5a854ef226870c2ca752b45069a.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56f6758e5fcdf49500a8578115843405.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2abea14906f57dad20b0431810b3f83.webp",980,1306]